Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (144,973)	$ (153,098)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization expense	1,103	4,853
Stock-based compensation	8,633	3,347
Loss on disposal of property and equipment	3,698	0
Change in fair value measurement of related party notes payable and notes payable	(79,462)	(1,186)
Change in fair value measurement of warrant liability	31,327	0
Change in fair value measurement of earnout liability	2,764	0
Amortization of operating lease right-of-use assets and intangible assets	736	0
Loss on foreign exchange	653	894
Non-cash interest expense	34	2,319
Loss on settlement of notes payable	98,136	0
Other	661	108
Changes in operating assets and liabilities:
Deposits	(12,108)	6,840
Other current and non-current assets	7,227	2,095
Accounts payable	(11,044)	5,747
Accrued expenses and other current liabilities	(9,626)	14,527
Operating lease liabilities	(542)	(882)
Accrued interest expense	(197)	(7,928)
Net cash used in operating activities	(102,980)	(122,364)
Cash flows from investing activities
Payments for property and equipment	(16,873)	(44,398)
Net cash used in investing activities	(16,873)	(44,398)
Cash flows from financing activities
Proceeds from notes payable, net of original issuance discount	131,800	0
Proceeds from exercise of warrants	4,079	0
Payments of notes payable	(6)	(87,065)
Settlement of notes payable transaction costs	(1,139)	0
Payments of finance lease obligations	(335)	(466)
Proceeds from exercise of stock options	44	1,855
Net cash (used in) provided by financing activities	134,443	(85,676)
Effect of exchange rate changes on cash and restricted cash	170	(653)
Net (decrease) increase in cash and restricted cash	14,760	(253,091)
Cash and restricted cash, beginning of period	18,514	530,477
Cash and restricted cash, end of period	33,274	277,386
Cash	31,769	276,374
Restricted cash	1,505	1,012
Total cash and restricted cash, end of period	33,274	277,386
Supplemental disclosure of cash flow information
Cash paid for interest	324	10,040
Supplemental disclosure of noncash investing and financing activities
Additions of property and equipment included in accounts payable and accrued expenses	17,249	1,881
Reclassification of liability for insufficient authorized shares related to stock options and RSUs	8,979	0
Reclassification of earnout shares liability to equity as part of authorized share increase	5,014	0
Conversion of convertible note to equity	138,180	0
Issuance of SPA Notes pursuant to the Exchange Agreement (Note 10)	41,000	0
Issuance of SPA Warrants pursuant to the Exchange Agreement (Note 10)	26,455	0
Disposal of SPA Warrants and ATW NPA Warrants pursuant to the Exchange Agreement (Note 10)	77,577	0
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange (Note 10)	6,811	0
Recognition of operating right of use assets and lease liabilities upon adoption of ASC 842 and for new leases entered into in 2022	$ 0	$ 8,206